Remove Bioequivalency Remove Generic Drugs Remove Licensing Remove Manufacturing
article thumbnail

Biosimilars vs. Interchangeable Biological Products: FDA Fact Check

XTalks

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “genericdrugs of the biopharma world.

article thumbnail

Cerelle vs Cerazette: Are they really the same?

Druggist

In terms of prescribing, both contraceptives are regarded as the same drug. . Although the active ingredient is the same, there are differences in non-active components (the core of the tablet and coating), which reflect both pills’ manufacturing process. Bioequivalent studies may involve humans or animals (EMA, 2012). .

article thumbnail

TLC Provides Corporate Update at Investor Conference – Dec 18, 2020

The Pharma Data

With experiences attained in licensing and business development functions from Amgen, Baxter and Johnson & Johnson, Mr. Bliss introduced himself in Mandarin Chinese. SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec. TLC is consistently ranked top 5% among all listed companies in Taiwan’s Corporate Governance Evaluations.